Protagonist Appoints William D. Waddill To Board
Executive Summary
Protagonist Therapeutics has appointed William D. Waddill, who is currently senior vice president (SVP) and chief financial officer (CFO) of Calithera Biosciences, to Protagonist’s board of directors. Before Calithera, Waddill was SVP and CFO at OncoMed Pharmaceuticals and prior to this he was SVP and CFO at Ilypsa. Before Ilypsa, he was the founder and principal at Square One Finance.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
Pipeline Watch: Six Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.